Investment portal Bioverge offers a new source of capital for seeding healthcare companies that have disruptive ideas. At the same time, its equity crowdfunding model is able to engage individual investors that have never before had the opportunity to invest in private companies.
Start-ups developing disruptive healthcare solutions almost inevitably have to pass through the proverbial “Valley of Death,” the journey that begins after a company is founded with a bit of funding from the NIH or other grantors, through the milestones of seed funding and the Series A round to more sustainability. Fledgling companies have a tough time here, and many don’t make it out. Investors generally regard unprecedented solutions as too risky, even when the problems start-ups are trying to solve are universally recognized as big ones.